Erythromycin-induced long QT syndrome: Concordance with quinidine and underlying cellular electrophysiologic mechanism
- 31 August 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 89 (2) , 235-238
- https://doi.org/10.1016/0002-9343(90)90305-w
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Pharmacological response of quinidine induced early afterdepolarisations in canine cardiac Purkinje fibres: insights into underlying ionic mechanismsCardiovascular Research, 1988
- The long QT syndromes: A critical review, new clinical observations and a unifying hypothesisProgress in Cardiovascular Diseases, 1988
- Proarrhythmic effects of antiarrhythmic drugsThe American Journal of Cardiology, 1987
- Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndromeThe American Journal of Cardiology, 1987
- QT prolongation and recurrent “torsades de pointes” during erythromycin lactobionate infusionThe American Journal of Cardiology, 1986
- Clinical features and basic mechanisms of quinidine-induced arrhythmiasJournal of the American College of Cardiology, 1986
- Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length.Circulation Research, 1985
- Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycinThe American Journal of Cardiology, 1984
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984
- Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.Circulation, 1983